3C
- Tim Whitlock (Deactivated)
Description
The 3C Study is a randomized trial investigating different immunosuppression strategies in kidney transplantation. It recruited 852 participants between 2010 and 2013 and these participants are now under long-term follow-up through registries to allow the trial to assess the long-term risks and benefits of the different treatments. A key outcome is transplant function which is assessed from creatinine measurements done routinely as part of transplant care and collected by UKRR. These data are critical to the long-term assessments.
Who
Richard Haynes richardhaynes@nhs.net
Data Sharing Agreement
DSA71
Data Supplied
Creatinine (including date of sample or date of quarter in which result collected)
If available: tacrolimus, sirolimus levels (including date of sample or date of quarter in which result collected)
Current RRT modality
First dialysis modality following transplant (and date of start)